Follow The Filings

OSUR OraSure Technologies

OraSure Technologies earnings company data as of 10:00 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by OSUR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OSUR insider trades
  • $551K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Steven Kyle Boyd Director
    Buy
    $225K 75,000 shares at $3.00 +195% to stake
    Traded May 12–14 Filed May 14
  2. Kenneth J McGrath CFO
    Buy
    $95K 32,300 shares at $2.93 +5.8% to stake
    Traded Mar 20 Filed Mar 23
  3. Manner Carrie Eglinton CEO
    Buy
    $95K 32,300 shares at $2.93 +1.5% to stake
    Traded Mar 20 Filed Mar 23
  4. Kenneth J McGrath CFO
    Buy
    $66K 22,021 shares at $3.00 +4.1% to stake
    Traded Mar 13 Filed Mar 16
  5. Manner Carrie Eglinton CEO
    Buy
    $66K 22,022 shares at $3.00 +1% to stake
    Traded Mar 13 Filed Mar 16
  6. Nancy J Gagliano Director
    Buy
    $4,982 2,100 shares at $2.37 +1.3% to stake
    Traded Nov 28, 2025 Filed Dec 2, 2025

Also filed in the last 12 months, not counted as buying or selling: 18 stock grants and 11 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
SCHEDULE 13D —
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 8.01
8-K 5.02,5.03,5.07,9.01
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G —
DEF 14A
SCHEDULE 13D/A —
8-K 1.01,5.02,7.01,9.01
DEFA14A
DEFA14A
SCHEDULE 13G —
8-K 7.01,9.01
DEFA14A
SCHEDULE 13G/A —
SCHEDULE 13D/A —
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.